ANDA 70444, held by Novitium Pharma. Flurazepam Hydrochloride.
As of Nov 16, 2026, ANDA 70444 (Flurazepam Hydrochloride), held by Novitium Pharma, was first approved by FDA on Mar 20, 1986, with 9 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 20, 1986 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Flurazepam Hydrochloride15MG · capsule;oral | Flurazepam Hydrochloride | Discontinued |
| Jan 17, 2023 | Supplement 15Labeling · Standard review | Approved | None posted |
| Feb 8, 2021 | Supplement 14Labeling · Standard review | Approved | None posted |
| Jan 17, 2017 | Supplement 12Labeling · Standard review | Approved | None posted |
| Aug 15, 1995 | Supplement 8Manufacturing | Approved | None posted |
| Jul 21, 1993 | Supplement 11Labeling | Approved | None posted |
| Aug 9, 1989 | Supplement 10Labeling | Approved | None posted |
| Jul 20, 1989 | Supplement 9Bioequivalence | Approved | None posted |
| Feb 3, 1988 | Supplement 7Manufacturing | Approved | None posted |
| May 5, 1986 | Supplement 1Manufacturing | Approved | None posted |
| Mar 20, 1986 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters